Clinical trial

Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee…

NCT01626677 · Medipost Co Ltd., Industry · Completed

Key facts

NCT number NCT01626677
Title Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect
Official title Long Term Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee
Lead sponsor Medipost Co Ltd., Industry
Collaborators Dong-A Pharmaceutical Co., Ltd. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Degenerative Osteoarthritis, Defect of Articular Cartilage
Intervention type Biological, Procedure
Interventions CARTISTEM, Microfracture
Enrollment 103
Start date Jun 1, 2012
Primary completion May 1, 2015
Completion May 1, 2015
First posted Jun 25, 2012
Last update posted Apr 20, 2017
Countries South Korea

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies